SHAREHOLDERS' EQUITY | NOTE 15:- SHAREHOLDERS' EQUITY a. Ordinary Shares: 1. Issuance of Ordinary Shares to directors and service provides: During the year ended December 31, 2014 the Company issued: a) 17,747 Ordinary Shares to Cukierman & Co., in consideration for non-exclusive investment-banking services and business development services to the Company (see Note 19a); b) 17,079 Ordinary Shares to Edouard Cukierman pursuant to his Active Chairman Agreement (see Note 19b); c) 6,004 Ordinary Shares and 2,405 Ordinary Shares to THCAP pursuant to a service agreement (see Note 19c) and as a director's fee, respectively; and d) 2,652 Ordinary Shares to other board members as a director's fee. During the year ended December 31, 2015, the Company issued 4,065 Ordinary Shares to Cukierman & Co., in consideration for non-exclusive investment-banking services and business development services to the Company (see Note 19a). During the year ended December 31, 2016, the Company issued 4,882 Ordinary Shares to a service provider, in consideration for his services in the business acquisition of iDnext (see Note 3). 2. Issuance of Ordinary Shares in connection with Standby Equity Distribution Agreement: On each of June 18, 2013, February 3, 2014 and February 17, 2015, the Company entered into a Standby Equity Distribution Agreement ("SEDA"), with YA Global Master SPV Ltd. ("YA" or "YA Global") for the sale of up to $600, $2,000 and $ 1,300, respectively, of its Ordinary Shares to YA. The Company may effect the For each Ordinary Share purchased under the SEDA, YA will pay 95% for 2013 and 2014 SEDA, and 93% for 2015 SEDA, of the lowest daily VWAP (as defined below) of the Ordinary Shares during the five consecutive trading days (or, for the 2015 SEDA, commencing June 2016, three consecutive trading days), following the date of an advance notice from the Company (provided such VWAP is greater than or equal to 90% of the last closing price of the Ordinary shares at the time of delivery of the advance notice). Notwithstanding the forgoing, the notice shall not exceed $150 for the 2013 SEDA, $500 for the 2014 and 2015 SEDA. "VWAP" is defined as of any date, to be such date's daily dollar volume-weighted average price of the Ordinary Shares as reported by Bloomberg, LP. The Company may terminate the SEDA at any time upon prior notice to YA Global, as long as there are no advance notices outstanding and the company has paid to YA all amounts then due. In connection with the 2013, 2014 and 2015 SEDA, the Company issued Ordinary shares to YA as a commitment fee of 7,500, 13,711 and 28,930, respectively. During the years 2014-2016, the Company issued to YA 1,031,515 Ordinary Shares, for a total amount of $2,783. 3. On February 3, 2014, the Company entered into a Note Purchase Agreement with YA under which YA provided the Company with a one year bridge loan in the amount of $500. The bridge loan was repayable in nine equal monthly installments commencing three months after the receipt of the loan and was paid in full throughout February 2015. The Company paid a commitment fee by issuance to YA of 2,500 Ordinary shares. 4. On November 27, 2014, the Company entered into a Share Purchase Agreement, for the sale to Novel Infrastructure, Ltd. ("Novel") of 128,147 Ordinary Shares for $500. The issuance costs related to this transaction were $33. 5. On June 10, 2015, the Company entered into a Share Purchase Agreement with certain investors, including YA Global, members of management, and certain business partners of the Company, under which the Company issued 244,630 Ordinary Shares and raised an aggregate amount $ 573, net of $ 16 issuance expenses, at a price per share of $2.406. 6. On January 8, 2015, the Company’s Board of Directors approved an increase of 1,500,000 Ordinary Shares in the Company's authorized share capital, from 2,500,000 authorized shares to 4,000,000 authorized shares. 7. On January 1, 2016 the Company issued 162,734 Ordinary Shares as part of the consideration for the iDnext business acquisition (see Note 3). b. Warrants to shareholders The Company's outstanding warrants to shareholders as of December 31, 2016 are as follows: Outstanding and exercisable warrants Weighted average exercise price of outstanding warrants Weighted average remaining contractual life (years) 161,000 7.43 0.56 In January 2014, the Company requested warrant holders who hold 161,000 warrants to defer registration of the shares underlying the warrants issued to them in order to enable the Company to register shares in connection with its Standby Equity Distribution Agreement with YA. In connection with such deferral, the warrants' exercise period was extended by an additional two years (to July 2017) and the exercise price was reduced from $11 to $7.43. The warrant holders have agreed to this arrangement, and it was approved by the Company's Audit Committee and Board of Directors. The extension of warrants held by Telegraph Hill Capital, an affiliate of a former member of the Company's Board of Directors, was approved also at the Company's shareholders meeting. c. Stock option plans: The term of Company's Israeli Stock Option Plan (the "Plan") is until May 31, 2023. On November 2016, the Company's shareholders approved an increase in the number of options for Ordinary Shares available for issuance under the Plan by 100,000, from 275,000 to 375,000. Any option which is canceled or forfeited before expiration will become available for future grants. As of December 31, 2016 there are 53,638 options available for future grants under the Plan. Each option granted under the Plan expires between 3-10 years from the date of the grant. The options vest gradually over a period of up to four years. A summary of the Company's employee and director stock option activity and related information for the year ended December 31, 2016, is as follows: 2016 2015 2014 Number of options Weighted- average exercise price Number of options Weighted average exercise price Number of options Weighted- average exercise price Outstanding - beginning of year 238,894 $ 6.65 136,256 $ 9.62 144,726 $ 14.80 Changes during the year: Granted 30,000 $ 2.13 109,625 $ 2.78 16,125 $ 5.70 Exercised (10,000 ) $ 2.96 - $ - - $ - Forfeited (6,224 ) $ 8.56 (6,987 ) $ 12.49 (24,595 ) $ 37.55 Outstanding - year end 252,670 $ 6.21 238,894 $ 6.65 136,256 $ 9.62 Vested and expected to vest 154,333 $ 8.44 88,766 $ 12.47 58,982 $ 16.64 Exercisable at year end 144,333 $ 8.82 88,766 $ 12.47 136,256 $ 9.62 During the years 2016, 2015, and 2014, stock-based compensation expense related to employees and directors stock options amounted to $ 124, $ 119 and $ 100, respectively, and is included in general and administrative expenses within the statement of operations. The weighted-average grant-date fair value of options granted during the years ended December 31, 2016, 2015 and 2014 was $ 2.08, $ 2.43 and $ 5.32, respectively. The weighted-average grant-date fair value of unvested options as of December 31, 2016 was $ 2.48. The aggregate intrinsic value of the outstanding options in each of the years ended December 31, 2016, 2015 and 2014 is $ 0. The aggregate intrinsic value represents the total intrinsic value (the difference between the fair market value of the Company's Ordinary Shares on December 31, 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2016. During the year ended December 31, 2016, 10,000 options were exercised. No options were exercised during the year ended on December 31, 2015. As of December 31, 2016 and 2015, there were a total of $ 98 and $ 187, respectively, of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Company's Plan. That cost is expected to be recognized through 2019. During the year ended December 31, 2016, the Company received $29.6 from the exercise of options. No cash was received from the exercise of options in the year ended December 31, 2015. Options granted to employees and directors that are outstanding as of December 31, 2016 broken into exercise prices, are as follows: Weighted average Options Weighted Options Remaining outstanding average exercisable Contractual as of remaining as of life of options Exercise December 31, contractual December 31, exercisable Price 2016 life (years) 2016 (years) 2.126 30,000 4.86 - - 2.237 26,625 3.81 8,873 - 2.96 73,000 3.38 17,666 3.38 3.23 375 0.14 375 0.14 3.88 375 2.88 250 2.88 3.88 90,000 1.85 90,000 1.85 4.02 5,000 2.54 3,333 2.54 6.67 10,000 2.28 6,666 2.28 6.67 375 2.28 250 2.28 33.60 3,750 1.23 3,750 1.23 50.40 13,170 0.30 13,170 0.30 Grand Total 252,670 2.80 144,333 2.07 |